Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection

Folia Histochemica et Cytobiologica

Volumn 45, Issue 4, 2007, Pages 357-366

  Kasprzak, Aldona ^a   Adamek, Agnieszka ^a   Biczysko, Wiesława ^a   Seidel, Jolanta ^a   Przybyszewska, Wiesława ^a   Olejniczak, Karolina ^a   Juszczyk, Jacek ^a   Zabel, Maciej ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chronic hepatitis C virus (HCV) infection; HCV proteins (core, NS3 and NS5A) subcellular localization; Proliferative marker Ki 67

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; AVIDIN; BIOTIN; KI 67 ANTIGEN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; PEROXIDASE; PROTEIN C; VIRUS RNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPLASM; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MALE; MITOCHONDRION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE; VIRUS PATHOGENESIS;

HEPATITIS C VIRUS;

EID: 38849141587     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev. 2005;5:215-229.
2. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat. 2004;11:383-393.
3. Arima N, Kao CY, Licht T, Padmanabham R, Sasaguri Y, Padmanabhan R. Modulation of cell growth by the hepatitis C nonstructural protein NS5A. J Biol Chem. 2001;276:12675-12684.
4. Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology. 2002;298:53-62.
5. Kao CF, Chen SY, Chen JY, Lee YHW. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene. 2004;23:2472-2483.
6. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. p53-dependent transcriptional repression of p21 (waf1) by hepatitis C virus NS3. J Gen Virol. 2001;82:2235-2241.
7. Sato Y, Kato J, Takimoto R et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut. 2006;55:1801-1808.
8. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Med. 1998;9:1065-1067.
9. Yasui K, Wakita T, Tsukijama-Kohara K et al. The native form and maturation process of hepatitis C virus core protein. J Virol. 1998;72:6048-6055.
10. Cho JW, Baek WK, Suh SI et al. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver. 2001;21:137-142.
11. Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol. 2001;75:1401-1407.
12. Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007;109:2490-2496.
13. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun. 2007;355:883-888.
14. Hourioux C, Patient R, Morin A et al. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut. 2007;56: 1302-1308.
15. Muramatsu S, Ishido S, Fujita T, Itoh M, Hotta H. Nuclear localization of he NS3 protein of hepatitis C virus and factors affecting the localization. J Virol. 1997;71:4954-4961.
16. Reyes GR. The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci. 2002;9:187-197.
17. Khabar KS, Polyak SJ. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. J Interferon Cytokine Res. 2002;22:1005-1012.
18. Suzuki R, Sakamoto S, Tsutsumi T et al. Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol. 2005;79:1271-1281.
19. Yamanaka T, Uchida M, Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun. 2002;294:521-527.
20. Wang T, Weinman SA. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J Gastroenterol Hepatol. 2006;21;Suppl 3:S34-37.
21. Rouille Y, Helle F, Delgrange D et al. Subcellular localization of hepatitis C structural proteins in a cell culture system that efficiently replicates the virus. J Virol. 2006;80:2832-2841.
22. Kasprzak A, Seidel J, Biczysko W, Wysocki J, Spachacz R, Zabel M. Intracellular localization of hepatitis C virus proteins (NS3 and C) in children with chronic hepatitis C. Liver Int. 2005;25:896-903.
23. Barba G, Harper F, Harada T et al. Hepatitis C virus core protein shows a cytoplasmic localisation and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA. 1997;94: 1200-1205.
24. Walker FM, Dazza MC, Dauge MC et al. Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem. 1998;46:653-660.
25. Dutta U, Kench J, Byth K et al. Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C. Hum Pathol. 1998;29:1279-1284.
26. Farinati F, Cardin R, D'Errico A et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIBI Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 1996;23:1468-1475.
27. Rodriguez-Diaz JL, Rosas-Camargo V, Vega-Vega O et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Clin Oncol. (R Coll Radiol.) 2007;19:197-203.
28. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis. 2002;6:335-347.
29. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem. 1981;29:577-580.
30. Volkmann M, Schiff JH, Hajjar Y et al. Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma. J Mol Med. 2001;79:594-600.
31. Gatter KC, Dunnill MS, Gerdes J, Stein H, Mason DY (1986) New approach to assessing lung tumours in man. J Clin Pathol. 1986;39:590-593.
32. Hu KQ, Kyulo NL, Lim N, Elhazim B, Hillebrand DJ, Bock T. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol. 2004;99:860-865.
33. Dries V, von Both I, Muller M et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology. 1999;29:223-229.
34. Hiramatsu N, Hayashi N, Haruna Y et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology. 1992;16:306-311.
35. Sansonno D, Dammacco F. Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology. 1993;18:240-245.
36. Gowans EJ. Distribution of markers of hepatitis C virus infection throughout the body. Sem Liv Dis. 2000;20:85-102.
37. Falcón V, Acosta-Rivero N, Chinea G et al. Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients. Biochem Biophys Res Commun. 2003; 305:1085-1090.
38. Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002;122:366-375.
39. Santolini E, Migliaccio G, La-Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994;68:3631-3641.
40. Shi ST. Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology. 2002;292:198-210.
41. Canchis PW, Ganzalez SA, Fiel MI et al. Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum α-fetoprotein. Liver Int. 2004;24:198-203.
42. Goldstein NS, Blue DE, Hankin R et al. Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationship with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores. Am J Clin Pathol. 1999;111:811-816.
43. Kronenberger B, Ruster B, Lee JH et al. Hepatocellular proliferation in patients with chronic hepatitic C and persistently normal and abnormal aminotnansferase levels. J Hepatol. 2000;33:640-647.
44. Watanuki A, Ohwada S, Fukusato T, Kawate S, Makita F, Morishita Y. Low MIB-1 labeling index in anti-HCV positive hepatocellular carcinoma. Int J Oncol. 1998;13:1017-1022.